nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.165	0.258	CbGbCtD
Eletriptan—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.137	0.214	CbGbCtD
Eletriptan—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.133	0.208	CbGbCtD
Eletriptan—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.126	0.196	CbGbCtD
Eletriptan—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0799	0.125	CbGbCtD
Eletriptan—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0379	CcSEcCtD
Eletriptan—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0321	CcSEcCtD
Eletriptan—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00956	0.0269	CcSEcCtD
Eletriptan—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00867	0.0244	CcSEcCtD
Eletriptan—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00753	0.0212	CcSEcCtD
Eletriptan—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.0188	CcSEcCtD
Eletriptan—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.0182	CcSEcCtD
Eletriptan—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.0177	CcSEcCtD
Eletriptan—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.0168	CcSEcCtD
Eletriptan—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00585	0.0165	CcSEcCtD
Eletriptan—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0163	CcSEcCtD
Eletriptan—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.0157	CcSEcCtD
Eletriptan—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.0146	CcSEcCtD
Eletriptan—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.0146	CcSEcCtD
Eletriptan—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.0146	CcSEcCtD
Eletriptan—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.0145	CcSEcCtD
Eletriptan—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.0142	CcSEcCtD
Eletriptan—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0131	CcSEcCtD
Eletriptan—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.0127	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.0126	CcSEcCtD
Eletriptan—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.0126	CcSEcCtD
Eletriptan—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.0124	CcSEcCtD
Eletriptan—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0115	CcSEcCtD
Eletriptan—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.0113	CcSEcCtD
Eletriptan—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00388	0.0109	CcSEcCtD
Eletriptan—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.0108	CcSEcCtD
Eletriptan—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.0105	CcSEcCtD
Eletriptan—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0104	CcSEcCtD
Eletriptan—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.00999	CcSEcCtD
Eletriptan—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00994	CcSEcCtD
Eletriptan—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.00974	CcSEcCtD
Eletriptan—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00947	CcSEcCtD
Eletriptan—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00929	CcSEcCtD
Eletriptan—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00925	CcSEcCtD
Eletriptan—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.00921	CcSEcCtD
Eletriptan—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.00905	CcSEcCtD
Eletriptan—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00885	CcSEcCtD
Eletriptan—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00863	CcSEcCtD
Eletriptan—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00855	CcSEcCtD
Eletriptan—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00831	CcSEcCtD
Eletriptan—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00818	CcSEcCtD
Eletriptan—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00818	CcSEcCtD
Eletriptan—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00788	CcSEcCtD
Eletriptan—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00762	CcSEcCtD
Eletriptan—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.00759	CcSEcCtD
Eletriptan—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00749	CcSEcCtD
Eletriptan—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00736	CcSEcCtD
Eletriptan—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00733	CcSEcCtD
Eletriptan—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00723	CcSEcCtD
Eletriptan—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00719	CcSEcCtD
Eletriptan—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00691	CcSEcCtD
Eletriptan—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00689	CcSEcCtD
Eletriptan—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00664	CcSEcCtD
Eletriptan—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00654	CcSEcCtD
Eletriptan—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.0065	CcSEcCtD
Eletriptan—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00648	CcSEcCtD
Eletriptan—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00632	CcSEcCtD
Eletriptan—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00628	CcSEcCtD
Eletriptan—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00628	CcSEcCtD
Eletriptan—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00625	CcSEcCtD
Eletriptan—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00623	CcSEcCtD
Eletriptan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00604	CcSEcCtD
Eletriptan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00601	CcSEcCtD
Eletriptan—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00577	CcSEcCtD
Eletriptan—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00572	CcSEcCtD
Eletriptan—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00571	CcSEcCtD
Eletriptan—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00568	CcSEcCtD
Eletriptan—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00564	CcSEcCtD
Eletriptan—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00554	CcSEcCtD
Eletriptan—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00536	CcSEcCtD
Eletriptan—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00534	CcSEcCtD
Eletriptan—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00516	CcSEcCtD
Eletriptan—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00514	CcSEcCtD
Eletriptan—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00508	CcSEcCtD
Eletriptan—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00493	CcSEcCtD
Eletriptan—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00491	CcSEcCtD
Eletriptan—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0049	CcSEcCtD
Eletriptan—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00486	CcSEcCtD
Eletriptan—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00481	CcSEcCtD
Eletriptan—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00469	CcSEcCtD
Eletriptan—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00465	CcSEcCtD
Eletriptan—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00463	CcSEcCtD
Eletriptan—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0046	CcSEcCtD
Eletriptan—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00457	CcSEcCtD
Eletriptan—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00452	CcSEcCtD
Eletriptan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0045	CcSEcCtD
Eletriptan—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00448	CcSEcCtD
Eletriptan—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00437	CcSEcCtD
Eletriptan—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00434	CcSEcCtD
Eletriptan—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00432	CcSEcCtD
Eletriptan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00426	CcSEcCtD
Eletriptan—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00426	CcSEcCtD
Eletriptan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00425	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00423	CcSEcCtD
Eletriptan—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00421	CcSEcCtD
Eletriptan—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00417	CcSEcCtD
Eletriptan—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00412	CcSEcCtD
Eletriptan—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00409	CcSEcCtD
Eletriptan—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00401	CcSEcCtD
Eletriptan—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00397	CcSEcCtD
Eletriptan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00395	CcSEcCtD
Eletriptan—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0039	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00372	CcSEcCtD
Eletriptan—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.0037	CcSEcCtD
Eletriptan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00367	CcSEcCtD
Eletriptan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00364	CcSEcCtD
Eletriptan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00363	CcSEcCtD
Eletriptan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0036	CcSEcCtD
Eletriptan—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00355	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00353	CcSEcCtD
Eletriptan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00352	CcSEcCtD
Eletriptan—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00349	CcSEcCtD
Eletriptan—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00349	CcSEcCtD
Eletriptan—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00337	CcSEcCtD
Eletriptan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00334	CcSEcCtD
Eletriptan—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00325	CcSEcCtD
Eletriptan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00323	CcSEcCtD
Eletriptan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00323	CcSEcCtD
Eletriptan—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00301	CcSEcCtD
Eletriptan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00293	CcSEcCtD
Eletriptan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00289	CcSEcCtD
Eletriptan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000993	0.0028	CcSEcCtD
Eletriptan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000959	0.0027	CcSEcCtD
Eletriptan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000922	0.0026	CcSEcCtD
Eletriptan—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000915	0.00258	CcSEcCtD
Eletriptan—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.00257	CcSEcCtD
Eletriptan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000909	0.00256	CcSEcCtD
Eletriptan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000862	0.00243	CcSEcCtD
Eletriptan—HTR7—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	8.65e-06	0.00284	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	8.62e-06	0.00283	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	8.59e-06	0.00282	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.55e-06	0.00281	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	8.45e-06	0.00278	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	8.42e-06	0.00277	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	8.42e-06	0.00276	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	8.39e-06	0.00276	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	8.14e-06	0.00267	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.06e-06	0.00265	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.01e-06	0.00263	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	7.91e-06	0.0026	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	7.67e-06	0.00252	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.59e-06	0.00249	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	7.56e-06	0.00248	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	7.54e-06	0.00248	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	7.5e-06	0.00246	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	7.49e-06	0.00246	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	7.45e-06	0.00245	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	7.34e-06	0.00241	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	7.3e-06	0.0024	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	7.18e-06	0.00236	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.16e-06	0.00235	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	7.13e-06	0.00234	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.09e-06	0.00233	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.06e-06	0.00232	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.04e-06	0.00231	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	6.99e-06	0.0023	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	6.99e-06	0.00229	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.9e-06	0.00227	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	6.89e-06	0.00226	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	6.89e-06	0.00226	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	6.85e-06	0.00225	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.85e-06	0.00225	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.81e-06	0.00224	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.8e-06	0.00224	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.77e-06	0.00222	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.66e-06	0.00219	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.62e-06	0.00218	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	6.56e-06	0.00216	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.51e-06	0.00214	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.51e-06	0.00214	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	6.48e-06	0.00213	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.47e-06	0.00213	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	6.41e-06	0.00211	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.33e-06	0.00208	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.3e-06	0.00207	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.3e-06	0.00207	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.29e-06	0.00206	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.26e-06	0.00206	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.26e-06	0.00206	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.25e-06	0.00205	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.22e-06	0.00204	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.13e-06	0.00201	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	6.13e-06	0.00201	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	5.95e-06	0.00195	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.95e-06	0.00195	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.93e-06	0.00195	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.9e-06	0.00194	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.77e-06	0.00189	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	5.76e-06	0.00189	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.73e-06	0.00188	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.73e-06	0.00188	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.72e-06	0.00188	CbGpPWpGaD
Eletriptan—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	5.7e-06	0.00187	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.69e-06	0.00187	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.61e-06	0.00184	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.59e-06	0.00184	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.57e-06	0.00183	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.56e-06	0.00183	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	5.55e-06	0.00182	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.5e-06	0.00181	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.47e-06	0.0018	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.4e-06	0.00177	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.35e-06	0.00176	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.32e-06	0.00175	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.27e-06	0.00173	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.25e-06	0.00173	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.25e-06	0.00172	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.24e-06	0.00172	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.23e-06	0.00172	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.2e-06	0.00171	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.09e-06	0.00167	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	5.08e-06	0.00167	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	5.05e-06	0.00166	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.03e-06	0.00165	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.96e-06	0.00163	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.89e-06	0.00161	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.89e-06	0.00161	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.86e-06	0.0016	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.83e-06	0.00159	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.81e-06	0.00158	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.79e-06	0.00157	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.76e-06	0.00156	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.67e-06	0.00153	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.62e-06	0.00152	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.53e-06	0.00149	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.47e-06	0.00147	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.44e-06	0.00146	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.41e-06	0.00145	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.32e-06	0.00142	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.27e-06	0.0014	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.24e-06	0.00139	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.21e-06	0.00138	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.18e-06	0.00137	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.16e-06	0.00137	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.08e-06	0.00134	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.07e-06	0.00134	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.07e-06	0.00134	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.06e-06	0.00133	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.06e-06	0.00133	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.05e-06	0.00133	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.03e-06	0.00132	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.02e-06	0.00132	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.02e-06	0.00132	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4e-06	0.00131	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.95e-06	0.0013	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.95e-06	0.0013	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.94e-06	0.00129	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.91e-06	0.00129	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.88e-06	0.00127	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.84e-06	0.00126	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.74e-06	0.00123	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.73e-06	0.00122	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.71e-06	0.00122	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.71e-06	0.00122	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.7e-06	0.00121	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.68e-06	0.00121	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.68e-06	0.00121	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.66e-06	0.0012	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.62e-06	0.00119	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.58e-06	0.00118	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.57e-06	0.00117	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.53e-06	0.00116	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.38e-06	0.00111	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.38e-06	0.00111	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.37e-06	0.00111	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.37e-06	0.00111	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.36e-06	0.0011	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.29e-06	0.00108	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.29e-06	0.00108	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.21e-06	0.00105	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.19e-06	0.00105	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.14e-06	0.00103	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.12e-06	0.00103	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.09e-06	0.00102	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.09e-06	0.00102	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.07e-06	0.00101	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.01e-06	0.000988	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.01e-06	0.000988	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3e-06	0.000985	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.98e-06	0.000979	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.97e-06	0.000976	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.95e-06	0.000968	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.89e-06	0.000951	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.83e-06	0.000929	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.82e-06	0.000926	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.74e-06	0.000899	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.74e-06	0.000899	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.73e-06	0.000897	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.62e-06	0.000861	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.61e-06	0.000856	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.6e-06	0.000854	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.57e-06	0.000844	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.55e-06	0.000838	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.54e-06	0.000836	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.53e-06	0.00083	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.51e-06	0.000823	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.48e-06	0.000813	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.45e-06	0.000806	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.41e-06	0.000792	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.41e-06	0.000792	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.4e-06	0.000787	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.39e-06	0.000786	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.34e-06	0.00077	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.33e-06	0.000764	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.29e-06	0.000753	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.2e-06	0.000723	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.2e-06	0.000722	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	2.18e-06	0.000715	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.18e-06	0.000715	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.16e-06	0.00071	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.12e-06	0.000696	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	2.06e-06	0.000677	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	2.06e-06	0.000676	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.01e-06	0.000661	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.01e-06	0.00066	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2e-06	0.000656	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.99e-06	0.000654	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.99e-06	0.000653	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.96e-06	0.000643	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.94e-06	0.000638	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.89e-06	0.000622	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.89e-06	0.000619	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.88e-06	0.000617	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.88e-06	0.000616	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.86e-06	0.000612	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.85e-06	0.000608	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.84e-06	0.000604	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	1.81e-06	0.000595	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.79e-06	0.000587	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.77e-06	0.000581	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	1.76e-06	0.000579	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.72e-06	0.000564	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.69e-06	0.000554	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.67e-06	0.00055	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.67e-06	0.000548	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.67e-06	0.000547	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.66e-06	0.000546	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.65e-06	0.000543	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.64e-06	0.000539	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.63e-06	0.000535	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.63e-06	0.000535	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.61e-06	0.00053	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.55e-06	0.000509	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.54e-06	0.000504	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.53e-06	0.000502	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.52e-06	0.0005	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.49e-06	0.00049	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.43e-06	0.00047	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	1.35e-06	0.000444	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.28e-06	0.000421	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.27e-06	0.000418	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.26e-06	0.000412	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.25e-06	0.00041	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.24e-06	0.000407	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.24e-06	0.000406	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.23e-06	0.000403	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.17e-06	0.000385	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.15e-06	0.000379	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.14e-06	0.000376	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.09e-06	0.000358	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.07e-06	0.000353	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.06e-06	0.000347	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.05e-06	0.000345	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.05e-06	0.000344	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.03e-06	0.000338	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1e-06	0.00033	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	9.88e-07	0.000325	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	9.79e-07	0.000322	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.66e-07	0.000317	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.5e-07	0.000312	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	8.24e-07	0.000271	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	8.05e-07	0.000264	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.83e-07	0.000257	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	7.58e-07	0.000249	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	7.55e-07	0.000248	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	7.52e-07	0.000247	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	6.46e-07	0.000212	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	4.96e-07	0.000163	CbGpPWpGaD
